LLLaurent Letrilliart

Laurent Letrilliart

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Laurent Letrilliart has a total of 150 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patient-Centered Clinical Decision Support for Recommended Screenings in French Primary Care: Protocol for a Multicenter Mixed Methods Feasibility Study

    by Pierre-Yves Meunier, Laurent Magaud, Romain Varnier, Emmie Goetz, Melinda Bekaddour, Ludivine Albert, Inès Khati, Ilhem Bensekka, Julie Haesebaert, Denis Maillet, et al.

    Background: Primary care professionals (PCPs) are responsible for identifying eligibility and supporting patient decisions for a wide range of recommended screenings. However, the number of recommendations (42 for adults in France), complex eligibility criteria, limited consultation time, and competing priorities hinder their systematic delivery. Clinical decision support systems (CDSSs) with patient decision aids may help structure prevention-focused consultations and support shared decision-making, but their feasibility and acceptability in routine primary care remain uncertain. As part of the Aide aux Dépistages Recommandés (ADER) research program, we developed Lianeli, a CDSS designed to provide individualized, patient-centered support for all nationally recommended screenings. Objective: ADER-Faisabilité (ADER-F) is a study with the primary objective of assessing the feasibility of implementing Lianeli in routine primary care by estimating the proportion of patients for whom the CDSS is used to completion. Secondary objectives are to (1) quantitatively and qualitatively describe implementation feasibility, (2) describe organizational adjustments and interprofessional work related to the intervention, (3) explore the association between interprofessional use of Lianeli, health literacy, social deprivation, and feasibility, and (4 and 5) estimate the proportion of eligible, overdue or never screened patients who engage in organized or opportunistic cancer screening, respectively. Methods: ADER-F is a noncomparative, multicenter feasibility study with a mixed methods design conducted in primary care centers in the Auvergne-Rhône-Alpes region in France. We plan to recruit 210 adult patients from 21 general practitioners (GPs) across 17 sites. During routine consultations, eligible patients will be invited to complete a self-administered digital health questionnaire in Lianeli, which applies guideline-based algorithms to identify recommended screenings. Within 60 days, patients will attend a dedicated screening consultation during which the GP will validate the patient’s responses, discuss benefits and harms of each screening using shared decision-making, and update the patient’s screening pathway. Quantitative data will include Lianeli metadata, sociodemographic characteristics, health literacy, social deprivation, implementation feasibility measures (Guideline Implementation with Decision Support [GUIDES]–based questionnaires), and usability measures (French version of the System Usability Scale [F-SUS]). Semistructured interviews with patients and PCPs will be analyzed thematically and integrated with quantitative findings in a convergent metasynthesis. Results: The ADER-F study was funded in 2023. Following ethics approval in October 2025 and French National Commission on Data Protection authorization in February 2026, recruitment started in March 2026, with a planned 2-month inclusion period and an overall study duration of 6 months. The results are expected to be published in 2027. Conclusions: ADER-F will provide evidence on the feasibility and acceptability of a patient-centered CDSS to support recommended screenings in French primary care. The findings will identify determinants of successful implementation, guide possible developments of the Lianeli software and care pathways, and determine whether a subsequent effectiveness study is justified. Trial Registration: ClinicalTrials.gov NCT07270926; https://clinicaltrials.gov/study/NCT07270926 International Registered Report Identifier (IRRID): PRR1-10.2196/89922

  • Open Access

    Patient-Centered Clinical Decision Support for Recommended Screenings in French Primary Care: Protocol for a Multicenter Mixed Methods Feasibility Study (Preprint)

    by Pierre-Yves Meunier, Laurent Magaud, Romain Varnier, Emmie Goetz, Melinda Bekaddour, Ludivine Albert, Inès Khati, Ilhem Bensekka, Julie Haesebaert, Denis Maillet, et al.

    BACKGROUND Primary care professionals (PCPs) are responsible for identifying eligibility and supporting patient decisions for a wide range of recommended screenings. However, the number of recommendations (42 for adults in France), complex eligibility criteria, limited consultation time, and competing priorities hinder their systematic delivery. Clinical decision support systems (CDSSs) with patient decision aids may help structure prevention-focused consultations and support shared decision-making, but their feasibility and acceptability in routine primary care remain uncertain. As part of the Aide aux Dépistages Recommandés (ADER) research program, we developed Lianeli, a CDSS designed to provide individualized, patient-centered support for all nationally recommended screenings. OBJECTIVE ADER-Faisabilité (ADER-F) is a study with the primary objective of assessing the feasibility of implementing Lianeli in routine primary care by estimating the proportion of patients for whom the CDSS is used to completion. Secondary objectives are to (1) quantitatively and qualitatively describe implementation feasibility, (2) describe organizational adjustments and interprofessional work related to the intervention, (3) explore the association between interprofessional use of Lianeli, health literacy, social deprivation, and feasibility, and (4 and 5) estimate the proportion of eligible, overdue or never screened patients who engage in organized or opportunistic cancer screening, respectively. METHODS ADER-F is a noncomparative, multicenter feasibility study with a mixed methods design conducted in primary care centers in the Auvergne-Rhône-Alpes region in France. We plan to recruit 210 adult patients from 21 general practitioners (GPs) across 17 sites. During routine consultations, eligible patients will be invited to complete a self-administered digital health questionnaire in Lianeli, which applies guideline-based algorithms to identify recommended screenings. Within 60 days, patients will attend a dedicated screening consultation during which the GP will validate the patient’s responses, discuss benefits and harms of each screening using shared decision-making, and update the patient’s screening pathway. Quantitative data will include Lianeli metadata, sociodemographic characteristics, health literacy, social deprivation, implementation feasibility measures (Guideline Implementation with Decision Support [GUIDES]–based questionnaires), and usability measures (French version of the System Usability Scale [F-SUS]). Semistructured interviews with patients and PCPs will be analyzed thematically and integrated with quantitative findings in a convergent metasynthesis. RESULTS The ADER-F study was funded in 2023. Following ethics approval in October 2025 and French National Commission on Data Protection authorization in February 2026, recruitment started in March 2026, with a planned 2-month inclusion period and an overall study duration of 6 months. The results are expected to be published in 2027. CONCLUSIONS ADER-F will provide evidence on the feasibility and acceptability of a patient-centered CDSS to support recommended screenings in French primary care. The findings will identify determinants of successful implementation, guide possible developments of the Lianeli software and care pathways, and determine whether a subsequent effectiveness study is justified. CLINICALTRIAL ClinicalTrials.gov NCT07270926; https://clinicaltrials.gov/study/NCT07270926 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/89922

  • Open Access

    REalist COllaborative eVAluation of a work disability prevention programme for breast cancer survivors: Protocol of the RECOVA-FASTRACS realist evaluation (Preprint)

    by Apolline Blazer, Sabrina Rouat, Laure Guittard, Pauline Drouin, Julien Péron, Béatrice Fervers, Julien Carretier, Guillaume Broc, Laurent Letrilliart, Jean-Baptiste Fassier, et al.

    Background: Women with breast cancer face many barriers to returning to work (RTW) after their treatment. The Facilitating and Sustaining the Return to Work After Breast Cancer (FASTRACS) intervention aims to facilitate and sustain functional RTW. Objective: The main objective of the RECOVA-FASTRACS (Realist Collaborative Evaluation of a Work Disability Prevention Program for Breast Cancer Survivors) study is to evaluate the processes using a realist approach that analyzes what works, how, for whom, and under what circumstances. Methods: The RECOVA-FASTRACS study uses a mixed methods design to assess the implementation, context, and impact mechanisms of the FASTRACS intervention. The qualitative analysis will include 2 main components: a trajectory analysis and a focus group assessment. The trajectory analysis will examine the experiences of women who participated in the intervention and key individuals involved in their RTW process. We will use semistructured interviews according to the multiple-case study method. Additionally, to explore organizational and professional practices, focus groups will be conducted with professionals who deliver the intervention. To analyze the trajectories, embedded and iterative integration will combine the qualitative findings with relevant quantitative data from the FASTRACS randomized controlled trial for 5 domains: personal situation, professional situation, RTW, care pathway, intervention tool use, and perceived usefulness. Results: The RECOVA-FASTRACS study received funding in 2022. Recruitment and qualitative data collection began in month 6. Final analyses are expected to be completed by the end of 2026, with dissemination of the main findings anticipated in late 2027. Conclusions: Our mixed methods realist evaluation will provide a detailed analysis of the intervention processes, helping to identify impact mechanisms within specific contexts. This approach is meant to ensure a more informed and realist deployment of the intervention by professionals following the study.

  • Open Access

    REalist COllaborative eVAluation of a work disability prevention programme for breast cancer survivors: Protocol of the RECOVA-FASTRACS realist evaluation (Preprint)

    by Apolline Blazer, Sabrina Rouat, Laure Guittard, Pauline Drouin, Julien Péron, Béatrice Fervers, Julien Carretier, Guillaume Broc, Laurent Letrilliart, Jean-Baptiste Fassier, et al.

    BACKGROUND Women with breast cancer face many barriers to return to work (RTW) after their treatment. The FAcilitating and SusTain the Return to work After breast Cancer (FASTRACS) intervention aims to facilitate and sustain functional RTW. OBJECTIVE The main objective of the RECOVA-FASTRACS study is to evaluate the processes of the using a realist approach that analyses what works, how, for whom and under what circumstances. METHODS The RECOVA-FASTRACS study uses a mixed-methods design to assess the implementation, context, and impact mechanisms of the FASTRACS intervention. The qualitative analysis will include two main components: a trajectory analysis and a focus group assessment. The trajectory analysis will examine the experience of women who participated in the intervention and key individuals involved in their RTW process. We will use semi-structured interviews according to the multiple-case study method. Additionally, to explore organisational and professional practices, focus groups will be conducted with professionals who deliver the intervention. RESULTS To analyse the trajectories, embedded and iterative integration will combine the qualitative findings, with relevant quantitative data from the FASTRACS randomised controlled trial for five domains (i.e. personal situation, professional situation, return to work, care pathway, intervention tool use and perceived usefulness). CONCLUSIONS Our mixed-methods realist evaluation will provide a detailed analysis of the intervention processes, helping to identify impact mechanisms within specific contexts. This approach is meant to ensure a more informed and realist deployment of the intervention by professionals following the study. CLINICALTRIAL

  • Risk factors and outcomes of not having a preferred doctor: a cross-sectional study based on data from the French main health insurance scheme

    by Jérôme Tourasse, Annaëlle Testud, Cyrille Colin, Marie Viprey, Laurent Letrilliart

    Background: In France, 90.1% of the population was registered with a preferred doctor in 2019. Objectives: To explore the risk factors and healthcare utilization associated with not being registered with a preferred doctor. Design and Setting: Population-based cross-sectional study conducted among insured individuals aged 16 years or above in the Lyon metropolitan area. Methods: Data was extracted from the French health insurance information system for the year 2019. Univariate and multivariate models were used to analyse the risk factors and healthcare utilization associated with not being registered with a preferred doctor. Results: Among 878 030 individuals, 12.2% were not registered with a preferred doctor. In multivariate analysis, individuals not registered with a preferred doctor were younger (OR up to 18.2 between 16 and 30 years, compared to those aged ≥ 75 years), more often male (OR = 1.13), lived more often in a high medical accessibility area (OR up to 1.13 in the fourth quartile, compared to the first quartile), had less often a low income (OR = 0.64) or a long-term condition status (OR = 0.30), than those registered. Individuals without a preferred doctor had fewer visits to a GP (OR = 0.09), to a specialist (OR = 0.15), and to an emergency department (OR = 0.35), fewer hospitalizations (OR for no hospitalization = 4.54), and fewer selected prevention procedures (OR as low as 0.06 for breast cancer screening). Conclusions: Not having a preferred doctor may limit access to primary and secondary care. Strategies to enhance registration should be considered, particularly for individuals with a long-term condition and those living in medically underserved areas.


  • CDSSs for health screening in primary care: a scoping review

    by Emma Garcia, Félicie Pierre, Pierre-Yves Meunier, Laurent Letrilliart

    INPLASY202410075 CDSSs for health screening in primary care: a scoping review Keywords: CDSS; health screening; primary care. Download PDF – 202410075 Review Status: Ongoing

  • Open Access

    Frequency and determinants of technical procedures in French general practice: a cross-sectional study

    by Victor Pointis, Henri Panjo, Anne-Marie Schott, Laurent Letrilliart

    RRH: Rural and Remote Health. Published article number: 7359 - Frequency and determinants of technical procedures in French general practice: a cross-sectional study


  • Antibiothérapie dans la prise en charge de la rhinosinusite frontale aiguë non compliquée de l’adulte. Une revue systématique de la littérature

    by Céline Maccio, Philippe Ceruse, Denis Pouchain, Laurent Letrilliart, Rémy Boussageon

  • Barriers and Facilitators to Participation in Health Screening: an Umbrella Review Across Conditions

    by Alice Le Bonniec, Sophie Sun, Amandine Andrin, Alexandra L. Dima, Laurent Letrilliart

    Screening is an essential prevention practice for a number of health conditions. However, screening coverage remains generally low. Studies that investigate determinants of screening participation are becoming more common, but oftentimes investigate screening for health conditions in an individualized rather than integrated fashion. In routine clinical practice, however, healthcare professionals are often confronted with situations in which several screening procedures are recommended for the same patient. The consideration of their common determinants may support a more integrated screening approach. The objectives of this umbrella review were therefore to examine: 1) the determinants (barriers and facilitators) that have been identified in relation to recommended health screening procedures; and 2) the modifiable determinants (in primary care) common across health conditions or specific to individual procedures. Results were presented through a narrative synthesis. PubMed, PsycInfo and Cochrane were searched up to January 2022. Systematic reviews reporting determinants of participation in health screening procedures with grade A or B recommendation according to the US Preventive Services Task Force were included. A total of 85 systematic reviews were included, most which contained both qualitative and quantitative studies on determinants that describe individual factors (961 occurrences), social factors (113 occurrences, healthcare professional factors (149 occurrences), health system factors (105 occurrences) and screening procedure factors (99 occurrences). The most studied screening procedures concerned cervical cancer/human papillomavirus (n = 33), breast cancer (n = 28), colorectal cancer (n = 25) and the human immunodeficiency virus (n = 12). Other conditions have been under-studied (e.g. cardiovascular problems, lung cancer, syphilis). The individual domain, including determinants such as knowledge, beliefs and emotions, was the most covered across health conditions. Healthcare professional’s recommendations and the quality of patient-provider communication were identified to have a strong influence on screening participation in most conditions. The other three domains included determinants which were more specific to a condition or a population. Various determinants modifiable in primary care were found in the individual domain and in the health system, healthcare professional and screening procedure domains. Quality was assessed as low for most systematic reviews included. The identification of various modifiable determinants common across conditions highlights the potential of an integrated screening participation approach. Interventions may address common determinants in a broader person-centred framework within which tailoring to specific procedures or populations can be considered. This approach needs to be explored in intervention studies. The systematic review registration is PROSPERO CRD42019126709.


  • Open Access

    General practitioner gender and use of diagnostic procedures: a French cross-sectional study in training practices

    by Amandine Bouissiere, Marine Laperrouse, Henri Panjo, Virginie Ringa, Laurent Rigal, Laurent Letrilliart

    Objectives The acceleration in the number of female doctors has led to questions about differences in how men and women practice medicine. The aim of this study was to assess the influence of general practitioner (GP) gender on the use of the three main categories of diagnostic procedures—clinical examinations, laboratory tests and imaging investigations. Design Cross-sectional nationwide multicentre study. Setting French training general practices. Participants The patient sample included all the voluntary patients over a cumulative period of 5 days per office between November 2011 and April 2012. The GP sample included 85 males and 43 females. Methods 54 interns in general practice, observing their GP supervisors, collected data about the characteristics of GPs and consultations, as well as the health problems managed during the visit and the processes of care associated with them. Using hierarchical multilevel mixed-effect logistic regression models, we performed multivariable analyses to assess differences in each of the three main categories of diagnostic procedures, and two specific multivariable analyses for each category, distinguishing screening from diagnostic or follow-up procedures. We searched for interactions between GP gender and patient gender or type of health problem managed. Results This analysis of 45 582 health problems managed in 20 613 consultations showed that female GPs performed more clinical examinations than male GPs, both for screening (OR 1.75; 95% CI 1.19 to 2.58) and for diagnostic or follow-up purposes (OR 1.41; 95% CI 1.08 to 1.84). Female GPs also ordered laboratory tests for diagnostic or follow-up purposes more frequently (OR 1.21; 95% CI 1.03 to 1.43). Female GPs performed even more clinical examinations than male GPs to diagnose or follow-up injuries (OR 1.69; 95% CI 1.19 to 2.40). Conclusion Further research on the appropriateness of diagnostic procedures is required to determine to what extent these differences are related to underuse or overuse.